Testing Streptococcinum to Reduce Repeated Tonsillitis in Children Aged 3?15 Years: A Randomized Study

To Ascertain The Efficacy Of Streptococcinum As An Intercurrent Remedy In Reducing The Recurrency Of Tonsillitis In Paediatric Age Group(3?15 Years): A Parallel Arm, Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094694

Enrollment

Registered

2025-09-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J350- Chronic tonsillitis and adenoiditis

Interventions

Intervention1: Streptococcinum: Streptococcinum is administered in 200C or 1M potency weekly or fortnightly Control Intervention1: 1. Belladonna 2. Hepar sulphur 3. Baryta carbonica 4. Mercurius solub

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 3?15 years 2. equal or more than 3 episodes in 6 months or equalor more than 5 in a year 3. Informed written consent and assent from guardians/parents/child 4. Each episode of tonsillitis must include one or more of the following, in addition to a sore throat: a. Temperature of 38.3?C (100.9?F) or higher. b. Tender cervical adenopathy (swollen lymph nodes in the neck). c. Tonsillar exudates (pus on the tonsils). d. A positive culture for Group A beta-hemolytic streptococcus (the bacteria that causes strep throat 5. Cases of recurrent tonsilitis ICD 11(CA0F.Y) and ICD 10(J35.0)

Exclusion criteria

Exclusion criteria: 1. Acute tonsillitis at time of enrolment 2. Prior tonsillectomy or planned surgery 3. Systemic chronic illness or immune disorders 4. Current use of other complementary therapies

Design outcomes

Primary

Measure	Time frame
1. The study is expected to show the effectiveness of Streptococcinum as an intercurrent remedy in reducing the cases of tonsillitis in children ages 3-15 years.7,9,1 2. The study is expected to show a comparison of the two groups, pointing out the difference in efficacy in the two groups and medicines used. 3. The study will help to find the average duration of medication required in cases of recurrent tonsillitis in ages 3-15yearsTimepoint: Evaluation of recurrent tonsillitis reported by the no. of episodes and the intensity. ? Evaluation in every 2 weeks ? Study end point: 6 months after the last registered case	—

Measure

Time frame

1. The study is expected to show the effectiveness of Streptococcinum as an intercurrent remedy in reducing the cases of tonsillitis in children ages 3-15 years.7,9,1 2. The study is expected to show a comparison of the two groups, pointing out the difference in efficacy in the two groups and medicines used. 3. The study will help to find the average duration of medication required in cases of recurrent tonsillitis in ages 3-15yearsTimepoint: Evaluation of recurrent tonsillitis reported by the no. of episodes and the intensity. ? Evaluation in every 2 weeks ? Study end point: 6 months after the last registered case

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactVanshika

Dr Madan Pratap Khunteta Homoeopathic Medical College Hospital And Research Centre

2108vanshika@gmail.com6239859337

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026